{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:07:59Z","timestamp":1790975279902,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1111020005"],"award-info":[{"award-number":["2023B1111020005"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30900650"],"award-info":[{"award-number":["30900650"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372501"],"award-info":[{"award-number":["81372501"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31430030"],"award-info":[{"award-number":["31430030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330065"],"award-info":[{"award-number":["82330065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572260"],"award-info":[{"award-number":["81572260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172232"],"award-info":[{"award-number":["81172232"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023B03J0106"],"award-info":[{"award-number":["2023B03J0106"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["20170402094"],"award-info":[{"award-number":["20170402094"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2020B1515120032"],"award-info":[{"award-number":["2020B1515120032"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2018A050506036"],"award-info":[{"award-number":["2018A050506036"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2021B1212040017"],"award-info":[{"award-number":["2021B1212040017"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.drup.2025.101291","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:33:31Z","timestamp":1755128011000},"page":"101291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy"],"prefix":"10.1016","volume":"83","author":[{"given":"Yanxia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fancheng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Situ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-7246","authenticated-orcid":false,"given":"Zunfu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101291_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112640","article-title":"Pharmacologic induction of BRCAness in BRCA-Proficient cancers: expanding PARP inhibitor use","volume":"14","author":"Abbotts","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101291_bib2","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/bjc.2012.451","article-title":"Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer","volume":"107","author":"Abkevich","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/2159-8290.CD-11-0206","article-title":"Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents","volume":"2","author":"Birkbak","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101291_bib4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"And DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2025.101291_bib5","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic Castration-Resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2025.101291_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fonc.2020.01103","article-title":"Spectrum of TP53 mutations in BRCA1\/2 associated High-Grade serous ovarian cancer","volume":"10","author":"Boyarskikh","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.trecan.2020.05.011","article-title":"DNA damage repair deficiency in prostate cancer","volume":"6","author":"Burdak-Rothkamm","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib8","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.20.03238","article-title":"Homologous recombination deficiency in pancreatic cancer: a systematic review and prevalence Meta-Analysis","volume":"39","author":"Casolino","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib9","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1038\/s41467-018-06136-x","article-title":"Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations","volume":"9","author":"Chang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101291_bib10","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1200\/JCO.2016.70.4627","article-title":"Reversion of BRCA1\/2 germline mutations detected in circulating tumor DNA from patients with High-Grade serous ovarian cancer","volume":"35","author":"Christie","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"Connor","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2025.101291_bib12","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"Digestives of and P. Intergroup, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101291_bib13","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1158\/0008-5472.CAN-22-1535","article-title":"BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer","volume":"82","author":"Foo","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101291_bib14","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/bjc.2014.418","article-title":"Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers","volume":"111","author":"Golan","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib16","first-page":"1","article-title":"Prevalence of homologous Recombination-Related gene mutations across multiple cancer types","author":"Heeke","year":"2018","journal-title":"JCO Precis Oncol. 2018"},{"key":"10.1016\/j.drup.2025.101291_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejca.2022.10.021","article-title":"Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: a current perspective","volume":"179","author":"Herzog","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2021.10.002","article-title":"Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trial","volume":"163","author":"Hodgson","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/djy085","article-title":"Biomarkers for homologous recombination deficiency in cancer","volume":"110","author":"Hoppe","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2025.101291_bib20","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1056\/NEJMoa2022485","article-title":"Survival with olaparib in metastatic Castration-Resistant prostate cancer","volume":"383","author":"Hussain","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101291_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103819","article-title":"Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment","volume":"29","author":"Khan","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drup.2025.101291_bib22","article-title":"Understanding the theranostic potential of quantum dots in cancer management","volume":"36","author":"Khan","year":"2023","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.drup.2025.101291_bib23","article-title":"Updates in clinical management of pancreatic cancer","volume":"22","author":"Ko","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.drup.2025.101291_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-021-09082-y","article-title":"Landscape of homologous recombination deficiencies in solid tumours: analyses of two independent genomic datasets","volume":"22","author":"Lai","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41698-023-00402-y","article-title":"HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients","volume":"7","author":"Li","year":"2023","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-020-01227-0","article-title":"PARP inhibitor resistance: the underlying mechanisms and clinical implications","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.gendis.2020.08.012","article-title":"Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice","volume":"9","author":"Mahdi","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.drup.2025.101291_bib29","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101291_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2021.5407","article-title":"Patterns of adjuvant chemotherapy use and association with survival in adults 80 years and older with pancreatic adenocarcinoma","volume":"8","author":"Mehtsun","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib31","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1038\/s41467-020-19406-4","article-title":"Pan-cancer landscape of homologous recombination deficiency","volume":"11","author":"Nguyen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101291_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and Long-term outcomes among patients with resected pancreatic cancer","volume":"310","author":"Oettle","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.drup.2025.101291_bib33","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.19.02931","article-title":"Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA\/PALB2 mutation","volume":"38","author":"O'Reilly","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4161\/15384101.2014.972901","article-title":"Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection","volume":"14","author":"Parameswaran","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.drup.2025.101291_bib35","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/1078-0432.CCR-20-0418","article-title":"Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection","volume":"26","author":"Park","year":"2020","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101291_bib36","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1158\/1078-0432.CCR-22-1483","article-title":"Clinico-genomic characterization of ATM and HRD in pancreas cancer: application for practice","volume":"28","author":"Park","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101291_bib37","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/nprot.2013.141","article-title":"Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications","volume":"8","author":"Pe\u00f1a-Llopis","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.drup.2025.101291_bib38","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1158\/0008-5472.CAN-12-1470","article-title":"Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1\/2 inactivation","volume":"72","author":"Popova","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101291_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115169","article-title":"Expert consensus, homologous recombination deficiency in ovarian cancer: global expert consensus on testing and a comparison of companion diagnostics","volume":"215","author":"Quesada","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib40","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101291_bib41","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as First-Line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101291_bib42","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1200\/JCO.21.00003","article-title":"Phase II study of maintenance rucaparib in patients with Platinum-Sensitive advanced pancreatic cancer and a pathogenic germline or somatic variant in BRCA1, BRCA2, or PALB2","volume":"39","author":"Reiss","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"10.1016\/j.drup.2025.101291_bib44","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1470-2045(23)00382-0","article-title":"Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial","volume":"24","author":"Saad","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101291_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112800","article-title":"Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: advancements and future perspectives","volume":"206","author":"Sameer Khan","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.drup.2025.101291_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101146","article-title":"Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma","volume":"77","author":"Shah","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101291_bib47","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2025.101291_bib48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2015.06.015","article-title":"Rad51 paralogs remodel Pre-synaptic Rad51 filaments to stimulate homologous recombination","volume":"162","author":"Taylor","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101291_bib49","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1158\/1078-0432.CCR-15-2477","article-title":"Homologous recombination deficiency (HRD) score predicts response to Platinum-Containing neoadjuvant chemotherapy in patients with Triple-Negative breast cancer","volume":"22","author":"Telli","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101291_bib50","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101291_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","article-title":"Drug resistance in ovarian cancer: from mechanism to clinical trial","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41416-019-0582-7","article-title":"Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation","volume":"122","author":"Wattenberg","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101291_bib53","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1158\/1078-0432.CCR-17-0544","article-title":"Diverse BRCA1 and BRCA2 reversion mutations in circulating Cell-Free DNA of Therapy-Resistant breast or ovarian cancer","volume":"23","author":"Weigelt","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101291_bib54","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1158\/1078-0432.CCR-21-2096","article-title":"Pan-cancer analysis of homologous recombination Repair-associated gene alterations and Genome-wide Loss-of-Heterozygosity score","volume":"28","author":"Westphalen","year":"2022","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101291_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.48721","article-title":"Prevalence of germline sequence variations among patients with pancreatic cancer in China","volume":"5","author":"Yin","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drup.2025.101291_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101085","article-title":"Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy","volume":"74","author":"Zhou","year":"2024","journal-title":"Drug Resist Updat"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:22:40Z","timestamp":1772886160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"alternative-id":["S1368764625000949"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101291","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101291"}}